Addressing the risk of monkeypox exposure during gastrointestinal endoscopy
Andrew Canakis, Raymond E. Kim, Pranay Sinha, Jean-Pierre Raufman
Comparative performance and external validation of three different scores in predicting inadequate bowel preparation among Greek inpatients undergoing colonoscopy
Paraskevas Gkolfakis, Christina Kapizioni, Georgios Tziatzios, Antonio Facciorusso, Leonardo Frazzoni, Konstantinos Thomopoulos, Spyridon Potamianos, Dimitrios Christodoulou, Vasilios Papadopoulos, Lorenzo Fuccio, Cessare Hassan, Konstantinos Triantafyllou
Liver biopsy in inflammatory bowel disease patients with sustained abnormal liver function tests: a retrospective single-center study
Emanuel Dias, Patrícia Andrade, Susana Lopes, Raquel Gonçalves, Pedro Cardoso, Rui Gaspar, Hélder Cardoso, Joanne Lopes, Fátima Carneiro, Guilherme Macedo
Successful initial tofacitinib treatment for acute severe ulcerative colitis with steroid resistance: a case series
Yoriaki Komeda, Masashi Kono, Hiroshi Kashida, George Tribonias, Sho Masaki, Ryutaro Takada, Tomoyuki Nagai, Satoru Hagiwara, Naoshi Nishida, Mamoru Takenaka, Hajime Honjo, Shigenaga Matsui, Naoko Tsuji, Masatoshi Kudo
First Impact Factor coming in 2023
We are delighted to announce that Annals of Gastroenterology will receive its first Impact Factor in 2023. According to Clarivate’s announcement on 26th July 2022, all journals currently in their ESCI collection, where Annals of Gastroenterology is presently indexed, will be awarded with an IF in June 2023.
